Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
12,13-diHOME Promotes Inflammatory Macrophages and Epigenetically Modifies Their Capacity to Respond to Microbes and Allergens.
Journal: Journal of immunology research
Published: December 21, 2023
Broad susceptibility of Candida auris strains to 8-hydroxyquinolines and mechanisms of resistance.
Journal: mBio
Published: July 26, 2023
Broad sensitivity of Candida auris strains to quinolones and mechanisms of resistance.
Journal: bioRxiv : the preprint server for biology
Published: February 24, 2023
Impact of a Multidisciplinary Post-COVID-19 Clinic on Hospital Admissions and ED Visits.
Journal: Chest
Published: July 08, 2022
Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19.
Journal: medRxiv : the preprint server for health sciences
Published: April 01, 2021
Rapid deployment of SARS-CoV-2 testing: The CLIAHUB.
Journal: PLoS pathogens
Published: October 28, 2020
Author Correction: Elevated faecal 12,13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance.
Journal: Nature microbiology
Published: September 08, 2019
Elevated faecal 12,13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance.
Journal: Nature microbiology
Published: February 26, 2019
Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients.
Journal: mBio
Published: August 18, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026